(Press-News.org) In a pilot study that included children at high risk for type 1 diabetes, daily high-dose oral insulin, compared with placebo, resulted in an immune response to insulin without hypoglycemia, findings that support the need for a phase 3 trial to determine whether oral insulin can prevent islet autoimmunity and diabetes in high-risk children, according to a study in the April 21 issue of JAMA, a theme issue on child health.
A few specific proteins are often the trigger for immune responses that cause autoimmune diseases. This has led to the experimental use of antigenspecific therapies (using a substance to initiate an immune response) to prevent, stabilize, or reverse immunerelated diseases, such as allergies and multiple sclerosis. Type 1 diabetes is an autoimmune disease that can be detected in asymptomatic individuals by the presence of islet autoantibodies that develop in children. Antigen-specific therapy using insulin before the development of autoantibodies may induce protective immune responses that prevent the emergence of autoimmunity and subsequent type 1 diabetes in genetically at-risk children, according to background information in the article.
Ezio Bonifacio, Ph.D., of the DFG Center for Regenerative Therapies Dresden, Technische Universitat Dresden, Germany and colleagues randomly assigned autoantibody-negative, genetically at-risk children to receive oral insulin at varying doses (n = 15) or placebo (n = 10) once daily for 3 to 18 months to assess whether oral insulin can induce a potentially protective immune response without causing adverse effects. The study (Pre-POINT) was performed between 2009 and 2013 in Germany, Austria, the United States, and the United Kingdom and enrolled children age 2 to 7 years with a family history of type 1 diabetes.
Immune responses to insulin were observed in 2 of 10 (20 percent) placebo-treated children, in 1 of 6 (16.7 percent) children treated with 2.5 mg of insulin, 1 of 6 (16.7 percent) treated with 7.5 mg, 2 of 6 (33.3 percent) treated with 22.5 mg, and 5 of 6 (83.3 percent) treated with 67.5 mg of insulin.
The incidence and type of adverse events were not different between children who received placebo and children who received oral insulin, regardless of the insulin dose. Hypoglycemia was not observed at any of the tested doses.
"The Pre-POINT pilot study demonstrated that daily oral administration of 67.5 mg of insulin to genetically at-risk healthy children without signs of islet autoimmunity resulted in an immune response without hypoglycemia. The immune response observed in insulin-treated children did not display the features typically associated with type 1diabetes," the authors write.
(doi:10.1001/jama.2015.2928; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Toward Primary Prevention of Type 1 Diabetes
"It is now possible to identify children at increased risk for type 1 diabetes at birth, and there is an identifiable sequence of events that culminates in impaired insulin secretion and overt type 1 diabetes," writes Jay S. Skyler, M.D., of the University of Miami Miller School of Medicine, in an accompanying editorial.
"What is missing are interventions to arrest this process prior to irreversible damage to the pancreatic beta cell. The promise of autoantigen-specific therapy for prevention of type 1 diabetes in humans has yet to be realized. The Pre-POINT study provides additional evidence to inform trial design and increases enthusiasm for cautiously moving forward with a study of primary prevention in genetically screened children."
(doi:10.1001/jama.2015.2054; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
INFORMATION:
The incidence of a potentially life-threatening complication of diabetes, diabetic ketoacidosis, in youth in Colorado at the time of diagnosis of type 1 diabetes increased by 55 percent between 1998 and 2012, suggesting a growing number of youth may experience delays in diagnosis and treatment, according to a study in the April 21 issue of JAMA, a theme issue on child health.
Diabetic ketoacidosis (DKA) at the time of type 1 diabetes (T1D) diagnosis has detrimental long-term effects and is characterized by dangerously high blood sugar and the presence of substances in ...
A multi-site study sponsored by the National Institute of Mental Health (NIMH) finds young children with autism spectrum disorder and serious behavioral problems respond positively to a 24-week structured parent training. The benefits of parent training endured for up to six months post intervention.
Published in the April 21 issue of the Journal of the American Medical Association the study found parent training was more effective in reducing disruptive and aggressive behavior than 24 weeks of parent education. Parent training provided parents with specific strategies ...
Researchers from the University of Tokyo have revamped an old e-paper concept to make an inexpensive handwriting-enabled e-paper well suited to large displays like whiteboards. They describe the e-paper in the Journal of Applied Physics, from AIP Publishing.
Traditional ink and paper is convenient for both reading and writing. In e-paper development the writing feature has generally lagged behind. Handwriting-enabled displays mainly show up in the inexpensive, but feature-limited realm of children's toys, and in the high-end realm of touch-screen e-readers and smart ...
French teams from CIC Biothérapie (AP-HP/Inserm), from pediatric hematology department of Necker Hospital for Children (AP-HP), led by Marina Cavazzana, Salima Hacein Bey Albina and Alain Fischer and from Genethon led by Anne Galy (Genethon/Inserm UMR-S951), and English teams from UCL Institute of Child Health and Great Ormond Street Hospital in London led by Adrian Thrasher and Bobby Gaspar demonstrated the efficacy of gene therapy treatment for Wiskott-Aldrich Syndrome (WAS). Six children that were treated and followed for at least 9 months had their immune system ...
BOULDER, Colo. -- In another advance at the far
frontiers of timekeeping by National Institute of
Standards and Technology (NIST) researchers, the
latest modification of a record-setting strontium atomic
clock has achieved precision and stability levels that
now mean the clock would neither gain nor lose one
second in some 15 billion years*--roughly the age of
the universe.
Precision timekeeping has broad potential
impacts on advanced communications, positioning technologies (such as GPS) and many
other technologies. Besides keeping future technologies on schedule, ...
Scientists from the DFG Center for Regenerative Therapies Dresden, TU Dresden and the Institut für Diabetesforschung, Helmholtz Zentrum München, together with researchers from Vienna, Bristol and Denver (USA) have successfully completed the first step in development of an insulin vaccine to prevent type 1 diabetes.
As reported by these diabetes researchers in the current edition of the renowned scientific journal JAMA, evaluations of the international Pre-POINT study point to a positive immune response in persons at risk for the disease who were given oral doses ...
AURORA, Colo. (April 21, 2015) - The incidence of a potentially life-threatening complication of diabetes, called diabetic ketoacidosis, increased by 55 percent between 1998 and 2012 in youth in Colorado, according to a study by researchers from the Barbara Davis Center for Childhood Diabetes and the University of Colorado School of Medicine on the Anschutz Medical Campus.
The finding is published in the April 21 issue of JAMA.
Diabetic ketoacidosis (DKA) at the time of type 1 diabetes diagnosis has detrimental long-term effects and is characterized by dangerously high ...
AURORA, Colo. (April 21, 2015) - Children at risk for type 1 diabetes, who were given daily doses of oral insulin, developed a protective immune response to the disease that researchers with the Barbara Davis Center for Childhood Diabetes at the University of Colorado Anschutz Medical Campus say could possibly lay the groundwork for a vaccine against the chronic illness.
The pilot study, published Tuesday, April 21, in the Journal of the American Medical Association (JAMA), was carried out in the U.S., Germany, Austria and the United Kingdom.
"This is the first time ...
Sweet potatoes from all over the world naturally contain genes from the bacterium Agrobacterium. Researchers from UGent and the International Potato Institute publish this discovery in PNAS. Sweet potato is one of the most important food crops for human consumption in the world. Because of the presence of this 'foreign' DNA, sweet potato can be seen as a 'natural GMO.'
The researchers discovered the foreign DNA sequences of Agrobacterium while searching the genome - this is the entire DNA-code - of sweet potato for viral diseases. Instead of contributing this peculiar ...
Female liver cells, and in particular those in menopaused women, are more susceptible to adverse effects of drugs than their male counterparts, according to new research carried out by the JRC. It is well known that women are more vulnerable when it comes to drug-induced liver effects, but it's the first time it has been shown that there are differences at cellular level. The findings are striking and clinically relevant, and emphasise the importance of considering sex-based differences in human health risk assessment.
In this study, five prevalently used drugs (diclofenac, ...
